M. Kelly, K. Stewart, L. Horton, O. Shana, and O. Kelley, Cell-penetrating peptides as delivery vehicles for biology and medicine, Org. Biomol. Chem, vol.6, pp.2242-2255, 2008.

S. Aroui, S. Brahim, M. D. Waard, and A. Kenani, Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cellpenetrating peptides in different cell lines: a comparative study, Biochem. Biophys. Res. Commun, vol.1, pp.391419-391425, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00587567

S. H. Kaufmann and W. C. Earnshaw, Induction of Apoptosis by Cancer Chemotherapy, Experimental Cell Research, vol.256, issue.1, pp.42-49, 2000.
DOI : 10.1006/excr.2000.4838

S. Shishodia, M. M. Chaturvedi, and B. B. Aggarwal, Role of Curcumin in Cancer Therapy, Current Problems in Cancer, vol.31, issue.4, pp.243-305, 2007.
DOI : 10.1016/j.currproblcancer.2007.04.001

Y. Deng, X. Ren, L. Yang, Y. Lin, and X. Wu, A JNK-Dependent Pathway Is Required for TNF??-Induced Apoptosis, Cell, vol.115, issue.1, pp.61-70, 2003.
DOI : 10.1016/S0092-8674(03)00757-8

C. Tournier, P. Hess, D. D. Yang, J. Xu, T. K. Turner et al., Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway, Science, vol.288, issue.5467, pp.870-874, 2000.
DOI : 10.1126/science.288.5467.870

M. Fan, M. Goodwin, T. Vu, C. Brantley-finley, W. A. Gaarde et al., Vinblastine-induced Phosphorylation of Bcl-2 and Bcl-XL Is Mediated by JNK and Occurs in Parallel with Inactivation of the Raf-1/MEK/ERK Cascade, Journal of Biological Chemistry, vol.275, issue.39, pp.275-29980, 2000.
DOI : 10.1074/jbc.M003776200

K. Lei, A. Nimnual, W. X. Zong, N. J. Kennedy, R. A. Flavell et al., The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-jun NH(2)-terminal kinase, Mol. Cell. Biol, issue.13, pp.22-4929, 2002.

K. Lei and R. J. Davis, JNK phosphorylation of bim-related members of the Bcl-2 family induces Bax-dependent apoptosis, Proc. Natl. Acad. Sci. USA, pp.2432-2437, 2003.

S. Aroui, S. Brahim, J. Hamelin, M. De-waard, J. Bréard et al., Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis, Apoptosis, vol.180, issue.3, pp.1352-1365, 2009.
DOI : 10.1007/s10495-009-0397-8

URL : https://hal.archives-ouvertes.fr/inserm-00515338

S. Aroui, S. Brahim, M. De-waard, J. Bréard, and A. Kenani, Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231, Cancer Letters, vol.285, issue.1, pp.28-38, 2009.
DOI : 10.1016/j.canlet.2009.04.044

URL : https://hal.archives-ouvertes.fr/inserm-00410230

S. Aroui, N. Ram, F. Appaix, M. Ronjat, A. Kenani et al., Maurocalcine as a Non Toxic Drug Carrier Overcomes Doxorubicin Resistance in the Cancer Cell Line MDA-MB 231, Pharmaceutical Research, vol.106, issue.Pt 4, pp.11095-11103, 2008.
DOI : 10.1007/s11095-008-9782-1

URL : https://hal.archives-ouvertes.fr/inserm-00356481

X. Wang, The expanding role of mitochondria in apoptosis, Genes Dev, vol.15, issue.22, pp.2922-2933, 2001.

C. Fleury, B. Mignotte, and J. L. Vayssiere, Mitochondrial reactive oxygen species in cell death signaling, Biochimie, vol.84, issue.2-3, pp.131-141, 2002.
DOI : 10.1016/S0300-9084(02)01369-X

W. Davis, Z. Ronai, and K. D. Tew, Cellular thiols and reactive oxygen species in drug-induced apoptosis, J. Pharmacol. Exp. Ther, pp.296-297, 2001.

F. Tsuruta, J. Sunayama, Y. Mori, S. Hattori, S. Shimizu et al., JNK promotes Bax translocation to mitochondria through phosphorylation of, EMBO J, vol.23, pp.14-17, 2004.

A. Ferreira, L. A. Matsubara, and L. S. Matsubara, Anthracycline-Induced Cardiotoxicity, Cardiovascular & Hematological Agents in Medicinal Chemistry, vol.6, issue.4, pp.278-281, 2008.
DOI : 10.2174/187152508785909474

P. H. Viale and D. S. Yamamoto, Cardiovascular Toxicity Associated With Cancer Treatment, Clinical Journal of Oncology Nursing, vol.12, issue.4, pp.627-638, 2008.
DOI : 10.1188/08.CJON.627-638

R. J. Davis, Signal Transduction by the JNK Group of MAP Kinases, Cell, vol.103, issue.2, pp.239-252, 2000.
DOI : 10.1016/S0092-8674(00)00116-1

Y. R. Chen and T. H. Tan, The c-Jun N-terminal kinase pathway and apoptotic signaling (review)., International Journal of Oncology, vol.16, pp.651-662, 2000.
DOI : 10.3892/ijo.16.4.651

T. Panaretakis, E. Laane, K. Pokrovskaja, A. C. Bjorklund, A. Moustakas et al., Doxorubicin Requires the Sequential Activation of Caspase-2, Protein Kinase C???, and c-Jun NH2-terminal Kinase to Induce Apoptosis, Molecular Biology of the Cell, vol.16, issue.8, pp.3821-3831, 2005.
DOI : 10.1091/mbc.E04-10-0862

S. Kharbanda, S. Saxena, K. Yoshida, P. Pandey, M. Kaneki et al., Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response toDNAdamage, J. Biol. Chem, pp.275-322, 2000.

C. G. Besirli and E. M. Johnson-jr, JNK-independent Activation of c-Jun during Neuronal Apoptosis Induced by Multiple DNA-damaging Agents, Journal of Biological Chemistry, vol.278, issue.25, pp.278-22357, 2003.
DOI : 10.1074/jbc.M300742200

]. Y. Mizutani, O. Yoshida, T. Miki, and B. Bonavida, Synergistic cytotoxicity and apoptosis by Apo-2 ligand and Adriamycin against bladder cancer cells, Clin. Cancer Res, vol.5, pp.2605-2612, 1999.

A. Lundqvist, S. I. Abrams, D. S. Schrump, G. Alvarez, D. Suffredini et al., Bortezomib and Depsipeptide Sensitize Tumors to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand: A Novel Method to Potentiate Natural Killer Cell Tumor Cytotoxicity, Cancer Research, vol.66, issue.14, pp.66-7317, 2006.
DOI : 10.1158/0008-5472.CAN-06-0680